Voting yes is a no brainer to me. If the company n

Voting yes is a no brainer to me. If the company needs money we need to authorize shares so we can continue to keep our head above water. All though… a yes vote needs a plan of use of these shares. I would like to hear exactly what the funds are for. To fund 1-2 or 3 or more trials? To fund all phase 3 trials for for Nash and mTNBC and finish up HIV combo and go right after HIV Mono?

We hired a new president and it’s not even fair for them to ask for shares/money until a future plan is laid out for all to see. This seems pre-emptive. Money/shares before plan?

I would say now that we have not partnered up with anyone with this big authorization of shares and when Dr. Kelly said they were going to model their future after a very smart Humira approvals in a platform drug working for our approvals the same smart way. It must be our own path alone of completing our very own path to approvals. No partners? Working for two approvals first before we even consider a buy-out?

I will probably vote yes on both proposals because we have to finance our company and this is how we do it in authorized shares. Nothing new here. We have obligations for manufacturing and needed trials. We need additional monies to get this accomplished.

All I can say is the announcement Monday of a new Cytodyn president should have a quote of Cyrus stating just what he plans to do to become our CEO and what the future under him looks like. If no plan is unveiled then maybe we don’t vote for authorizing this many shares and make them cut back.

If Cytodyn is looking to investors to build faith in our new management. Then they better be up front with a plan of direction of what the future plan is.